| Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng, S Luo, Z Li, P Liu, J Han, ... Pharmacological reviews 73 (3), 924-967, 2021 | 486 | 2021 |
| Suppressors of cytokine signaling-1 and-6 associate with and inhibit the insulin receptor: a potential mechanism for cytokine-mediated insulin resistance RA Mooney, J Senn, S Cameron, N Inamdar, LM Boivin, Y Shang, ... Journal of Biological Chemistry 276 (28), 25889-25893, 2001 | 387 | 2001 |
| COVID-19 and cardiovascular disease: from bench to bedside MK Chung, DA Zidar, MR Bristow, SJ Cameron, T Chan, CV Harding III, ... Circulation research 128 (8), 1214-1236, 2021 | 319 | 2021 |
| Antibody to human leukocyte antigen triggers endothelial exocytosis M Yamakuchi, NC Kirkiles-Smith, M Ferlito, SJ Cameron, C Bao, ... Proceedings of the National Academy of Sciences 104 (4), 1301-1306, 2007 | 165 | 2007 |
| SARS-CoV-2 initiates programmed cell death in platelets M Koupenova, HA Corkrey, O Vitseva, K Tanriverdi, M Somasundaran, ... Circulation research 129 (6), 631-646, 2021 | 142 | 2021 |
| SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy MK Chung, S Karnik, J Saef, C Bergmann, J Barnard, MM Lederman, ... EBioMedicine 58, 2020 | 129 | 2020 |
| Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase 1/ERK5 but not ERK1/2 kinase activation SJ Cameron, S Malik, M Akaike, N Lerner-Marmarosh, C Yan, JD Lee, ... Journal of Biological Chemistry 278 (20), 18682-18688, 2003 | 127 | 2003 |
| Ambient fine particulate air pollution triggers ST-elevation myocardial infarction, but not non-ST elevation myocardial infarction: a case-crossover study B Gardner, F Ling, PK Hopke, MW Frampton, MJ Utell, W Zareba, ... Particle and fibre toxicology 11, 1-11, 2014 | 118 | 2014 |
| Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients OF Laterza, SJ Cameron, D Chappell, LJ Sokoll, GB Green Clinica chimica acta 348 (1-2), 163-169, 2004 | 110 | 2004 |
| HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size M Yamakuchi, JJM Greer, SJ Cameron, K Matsushita, CN Morrell, ... Circulation research 96 (11), 1185-1192, 2005 | 98 | 2005 |
| Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions M Yang, BC Cooley, W Li, Y Chen, J Vasquez-Vivar, NO Scoggins, ... Blood, The Journal of the American Society of Hematology 129 (21), 2917-2927, 2017 | 80 | 2017 |
| Aldosterone activates endothelial exocytosis Y Jeong, DF Chaupin, K Matsushita, M Yamakuchi, SJ Cameron, ... Proceedings of the National Academy of Sciences 106 (10), 3782-3787, 2009 | 77 | 2009 |
| Antithrombotic therapy in abdominal aortic aneurysm: beneficial or detrimental? SJ Cameron, HM Russell, AP Owens III Blood, The Journal of the American Society of Hematology 132 (25), 2619-2628, 2018 | 72 | 2018 |
| Specificity and mechanism of Acinetobacter baumanii nicotinamidase; implications for activation of the front line TB drug pyrazinamide. PK Fyfe, VA Rao, A Zemla, S Cameron, WN Hunter Angewandte Chemie (International ed. in English) 48 (48), 9176, 2009 | 69 | 2009 |
| Associations between ambient wood smoke and other particulate pollutants and biomarkers of systemic inflammation, coagulation and thrombosis in cardiac patients DP Croft, SJ Cameron, CN Morrell, CJ Lowenstein, F Ling, W Zareba, ... Environmental research 154, 352-361, 2017 | 65 | 2017 |
| Platelet extracellular regulated protein kinase 5 is a redox switch and triggers maladaptive platelet responses and myocardial infarct expansion SJ Cameron, SK Ture, D Mickelsen, E Chakrabarti, KL Modjeski, S McNitt, ... Circulation 132 (1), 47-58, 2015 | 57 | 2015 |
| Differential role of MEK5α and MEK5β in BMK1/ERK5 activation SJ Cameron, J Abe, S Malik, W Che, J Yang Journal of Biological Chemistry 279 (2), 1506-1512, 2004 | 55 | 2004 |
| A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes SJ Cameron, LJ Sokoll, OF Laterza, S Shah, GB Green Clinica chimica acta 376 (1-2), 168-173, 2007 | 54 | 2007 |
| Activation of big MAP kinase 1 (BMK1/ERK5) inhibits cardiac injury after myocardial ischemia and reperfusion SJ Cameron, S Itoh, CP Baines, C Zhang, S Ohta, W Che, M Glassman, ... FEBS letters 566 (1-3), 255-260, 2004 | 51 | 2004 |
| Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo M Yang, A Kholmukhamedov, ML Schulte, BC Cooley, NO Scoggins, ... Blood Advances 2 (21), 2848-2861, 2018 | 50 | 2018 |
Craig MorrellUniversity of RochesterVerified email at urmc.rochester.edu
